Neuraminic Acids

Name
Neuraminic Acids
Accession Number
DBCAT000970
Description

Nine-carbon deoxyamino SUGAR ACIDS that are substrates for NEURAMINIDASE. Their derivatives include SIALIC ACIDS.

Drugs
DrugDrug Description
ZanamivirA neuraminidase inhibitor used to treat influenza A and B.
Laninamivir octanoateLaninamivir octanoate has been used in trials studying the treatment of Asthma.
LaninamivirLaninamivir has been used in trials studying the treatment of Influenza.
ColeneuramideColeneuramide is under investigation in clinical trial NCT00307749 (Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy).
2-deoxy-2,3-dehydro-N-acetylneuraminic acidNot Available
Drugs & Drug Targets
DrugTargetType
ZanamivirNeuraminidasetarget
ZanamivirNeuraminidasetarget
ZanamivirSialidase-2target
2-deoxy-2,3-dehydro-N-acetylneuraminic acidHemagglutinin-neuraminidasetarget
2-deoxy-2,3-dehydro-N-acetylneuraminic acidSialidasetarget
2-deoxy-2,3-dehydro-N-acetylneuraminic acidNeuraminidasetarget
2-deoxy-2,3-dehydro-N-acetylneuraminic acidHemagglutinin-neuraminidasetarget
2-deoxy-2,3-dehydro-N-acetylneuraminic acidSialidase-2target